Cargando…
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
Stroke is the world's second leading cause of mortality, with a high incidence of severe morbidity in surviving victims. There are currently relatively few treatment options available to minimize tissue death following a stroke. As such, there is a pressing need to explore, at a molecular, cell...
Autores principales: | Woodruff, Trent M, Thundyil, John, Tang, Sung-Chun, Sobey, Christopher G, Taylor, Stephen M, Arumugam, Thiruma V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037909/ https://www.ncbi.nlm.nih.gov/pubmed/21266064 http://dx.doi.org/10.1186/1750-1326-6-11 |
Ejemplares similares
-
Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death
por: Thundyil, John, et al.
Publicado: (2010) -
Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke
por: Widiapradja, Alexander, et al.
Publicado: (2014) -
Over-Expression of DSCR1 Protects against Post-Ischemic Neuronal Injury
por: Brait, Vanessa H., et al.
Publicado: (2012) -
Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury
por: Thundyil, John, et al.
Publicado: (2013) -
IL-37 increases in patients after ischemic stroke and protects from inflammatory brain injury, motor impairment and lung infection in mice
por: Zhang, Shenpeng R., et al.
Publicado: (2019)